ABSTRACT Background: It is estimated that every year 8 million new cases of tuberculosis occur globally and that 2 to 3 million people die annually from the disease. Human genetic variation is an important determinant of the outcome of infection with Mycobacterium tuberculosis. The aim of this study is to determine genetic susceptibility to tuberculosis among patients and their control by identifying the frequency of some IFNγR1 polymorphisms in development of susceptibility to pulmonary tuberculosis in Gezira state of Central Sudan.
INTRODUCTION
During the last few years it has become clear that; the genotype of the host plays an important role in the evolution and outcome of infectious diseases. Considering tuberculosis, there still no satisfactory explanation for the fact that small proportion of individuals infected with Mycobacterium tuberculosis develop a severe clinical disease while others developed immunity against mycobacterial infections. Differences between Mycobacterium isolates from different patients with different clinical phenotypes of tuberculosis have not been fully demonstrated. Many host genes are involved in the control of the internal environment which the Mycobacterium faces and should favor the survival internally within the host genes that confer some protection against the infections. Considerably, more evidences are available to indicate the importance of host factors in determining the clinical presentations of mycobacterial infection. The full knowledge of these factors is important not only to understand how the disease evolves within an individual, but also of great importance to understand, from an epidemiological point of view, how it behaves in a given population.
Many of the cytokine-binding receptors function in the immune and hematopoietic systems (Casanova et al., 2001) . (Casanova et al., 2001) .
The polymorphisms in IFNgR1 inhibit signaling that introduced by IFNγ to phagocytes that produced more activity against M. tuberculosis in many studies that confirm this fact. (Newport, 2004 , Newport et al., 1996 .
Complete IFN-g receptor ligandbinding chain (IFNγR1) deficiency is a life threatening autosomal recessive immune disorder. Affected children invariably die of mycobacterial infection, unless bone marrow transplantation is undertaken.
Pathogenic IFNgR1 mutations identified to date include nonsense, splice mutations, frame shift deletions and insertions. All result in a premature stop codon upstream from the segment encoding the transmembrane domain, precluding cell surface expression of the receptors.
MATERIALS AND METHODS
The 
Genetic Analysis
2-3 ml of venous blood were collected from each study and control subject into 3.8% sodium citrate and DNA extraction was performed using salting out method (ref) and the quality of DNA was measured by UV spectrophotometer.
PCR reactions was performed in a total volume of 30 µl containing 100 ng genomic DNA, 20 Pico moles of each primer, 200 µM dNTP, 3µl from 10 x Taq Gold Buffer (100mM Tris HCl, pH 8.3, 500 mM KCl, 15 mM MgCl 2 and 0.01 % (w/v) gelatin (Perkin Elmer Cetus), 1.5 U AmpliTaq GoldTM polymerase (Perkin Elmer Cetus) and was completed to the final volume with deionized water.
Mutation Analysis
In this study, polymorphisms in Interferon gamma receptor 1 (IFNgR1) IFNγR1-56 in exon 1 were screened in cases and controls by PCR-RFLP. 
Screening of

Digestion with Restriction Enzyme (Eco 47Щ)
In transition replacement of cyctine to thiamin in position -56 create a new restriction site for Eco 47Щ. In a total volume of 15 µl, 5 µl PCR products was digested overnight with 3µl Eco 47Щ enzyme and mixed with1.5 µl Buffer3 10x , 0.2 µl BSA 50µg and 7.8 µl deionized water.
The Digested DNA samples were mixed with 5 µl loading dye before being loaded on a 10 % Non-denaturaning polyacrylamide gel and electrophoresed at 100 V for two hours. Then the gel was stained in 0.1 µg/ml ethidium bromide solution for 10-15 minutes and visualized under UV light in Gel Documentation System (GDS).
The genotype was assigned according to the length of obtained fragments. 
RESULTS
Study Subjects
The mean age of the study subjects was (37.27 ± 16.1) years old; the minimum age was 10 years and the maximum was 95 years old. 92 (73%) were males and 34 (27%) were females Genetic Analysis IFNgR1-56 Genotypes in TB Patients and Controls IFNγR1 -56polymorphism were screened using PCR-RFLP method (Fig.1 ). Lane 10: M: 100-bp DNA marker. Lanes 2,3,4,5,6 and 9 were heterozygous (TC); Lanes 1 and 8 were homozygous (TT) for IFNgR1 -56 while Lane 7 is homozygous (CC) for IFNγR1-56.
The distribution of IFNγR1-56 T<C genotype show no significant difference between TB patients and controls (P = 0.071). The distribution of IFNγR1 -56 C >T genotype differ significantly between TB patients and controls (P = 0.017) (Fig.2) . That indicate the T allele is associate with two times increased risk to pulmonary tuberculosis than C allele (Pvalue = 0.017, odds ratio = 1.6, 95% CI = 1.025 -1.441). 
DISCUSSION
Tuberculosis is a social disease that is extremely sensitive to changes in the standard of living. The disease is an infection that is primarily spread and transmitted directly from human being to human being. The degree of crowdness and the congested houses are therefore important factors in the spreading of the disease (Puranen, 2003) that is the same factors that is found in rural community beside the direct contact between the populations. In this study the distribution of study subject according to locality showed that 89 (71%) were from rural area and 37 (29%) were from the urban areas.
Different genotypes seem to respond differently to environmental risk factors. Host genetic factors have an important role in the development of clinical disease following infection with tuberculosis, but inheritance of TB susceptibility in the general population is non-Mendelian. The correlation between the molecular pathology, mycobacterial virulence, and clinical phenotype in inherited IFNgR1 deficiency suggests that more subtle variation in IFNgR1 could contribute to M .tuberculosis disease susceptibility in an outbred population (Awomoyi et al. 2004) .
The distribution of IFNγR1 -56 C >T genotype differs significantly between TB patients and controls and those carrying the mutant C allele were associated with two times reduced risk for susceptibility to TB (P-value = 0.017, odds ratio = 1.6, 95% CI = 1.025 -1.441).
That means the mutation IFNgR1-56 CC give protection two times according to this result, that consistent with result of the study uses population collections from the Gambia, Guinea Bissau, and the Republic of Conakry. All cases were confirmed by either two consecutive smear-positive samples or a positive Mycobacterium tuberculosis (MTB) culture, and that found there is evidence from an in vitro model of cell expression that constructs bearing the IFNgR1-56 C allele produce less transcriptional activity in a standard assay system. If these findings can be translated into the clinical setting, might expect individuals with the IFNgR1-56 CC genotype to express less IFNgR1 receptor on the cell surface. It is perhaps surprising that this genotype is associated with protection from pulmonary tuberculosis in West African populations. A reduced immune response mediated by IFNgR1 could protect against pulmonary immunopathology, but given everything else that is known about IFNgR1, this explanation seems unlikely. More plausibly is that either another variant exists in linkage disequilibrium that might explain the disease association or that the functional role of this polymorphism has not yet been fully characterized (Graham et al.2006) In conclusion, the mutant C allele in the IFNgR1-56 is associated with two times increased protection to tuberculosis infection. However, more genetic studies are needed, to identify genes associated with susceptibility to tuberculosis. Williamson R, et al. (1996) Mutation in the interferon-gamma receptor gene and susceptibility to mycobacterial infections in man. N. Engl. J. Med. 335:1941 -1949 . 
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